Pfizer to pay $3.3 million to settle antibiotic marketing case
SALEM, Ore. — Pfizer Inc. has agreed to pay the state of Oregon more than $3.3 million to settle claims that the company used misleading statements and studies to market Zyvox, an antibiotic used to treat pneumonia and bacterial skin infections, The Washington Post reported.
According to a two-year state investigation, Pfizer used “unreliable and unsubstantiated claims” in marketing Zyvox as a better choice than a cheaper, generic antibiotic.
The state Justice Department alleged Pfizer’s sales representatives distributed copies of flawed clinical studies throughout Oregon to support the marketing claims.
Pfizer denies any wrongdoing.